Cargando…
Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre
Autores principales: | Al Lawati, Hatim, Nadar, Sunil K., Al Riyami, Adil B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645511/ https://www.ncbi.nlm.nih.gov/pubmed/36407690 http://dx.doi.org/10.18295/squmj.3.2022.020 |
Ejemplares similares
-
Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
por: Sorbini, M, et al.
Publicado: (2023) -
Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care
por: Faber, Lothar
Publicado: (2014) -
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008) -
Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
por: See, Vincent Y., et al.
Publicado: (2023) -
Yield of Cardiac Investigations in Patients Presenting with Acute Ischaemic Stroke: A single tertiary centre experience
por: Alshukri, Azhaar, et al.
Publicado: (2023)